C. Heydt, J. Fassunke, H. Kunstlinger, M. A. Ihle, K. Konig et al., Comparison of pre-analytical FFPE sample preparation methods and their impact on massively parallel sequencing in routine diagnostics, PLoS One, vol.9, issue.8, p.104566, 2014.

M. Simbolo, M. Gottardi, V. Corbo, M. Fassan, A. Mafficini et al., DNA qualification workflow for next generation sequencing of histopathological samples, PLoS One, vol.8, issue.6, p.62692, 2013.

B. G. Wang, H. Y. Huang, Y. C. Chen, R. E. Bristow, K. Kassauei et al., Increased plasma DNA integrity in cancer patients, Cancer Res, vol.63, pp.3966-3968, 2003.

E. Sunami, A. T. Vu, S. L. Nguyen, and D. S. Hoon, Analysis of methylated circulating DNA in cancer patients' blood, Methods Mol. Biol, vol.507, pp.349-356, 2009.

G. P. Mcdermott, D. Do, C. M. Litterst, D. Maar, C. M. Hindson et al., Multiplexed target detection using DNA-binding dye chemistry in droplet digital PCR, Anal. Chem, vol.85, pp.11619-11627, 2013.

A. Didelot, S. K. Kotsopoulos, A. Lupo, D. Pekin, X. Li et al., Multiplex picoliter-droplet digital PCR for quantitative assessment of DNA integrity in clinical samples, Clin. Chem, vol.59, pp.815-823, 2013.
URL : https://hal.archives-ouvertes.fr/inserm-02299583

J. A. Glasel, Validity of nucleic acid purities monitored by 260 nm/280 nm absorbance ratios, Biotechniques, vol.18, pp.62-63, 1995.

C. F. Barbas-3rd, D. R. Burton, J. K. Scott, and G. J. Silverman, Quantitation of DNA and RNA, Cold Spring Harb. Protoc, 2007.

C. Robertson, Spectrophotometry's Next-Generation Technology, American Biotechnology Laboratory, 2003.

K. Rengarajan, S. M. Cristol, M. Mehta, and J. M. Nickerson, Quantifying DNA concentrations using fluorometry: a comparison of fluorophores, Mol. Vis, vol.8, pp.416-421, 2002.

S. Deo, Essentials of nucleic acid analysis: a robust approach, Anal. Bioanal. Chem, vol.392, pp.321-322, 2008.

I. Johnson and M. T. Spence, The Molecular Probes ® Handbook-A Guide to Fluorescent Probes and Labeling Technologies, 2010.

R. Batel, Z. Jaksic, N. Bihari, B. Hamer, M. Fafandel et al., A microplate assay for DNA damage determination, Anal. Biochem, vol.270, pp.195-200, 1999.

H. Swerdlow and R. Gesteland, Capillary gel electrophoresis for rapid, high resolution DNA sequencing, Nucleic Acids Res, vol.18, pp.1415-1419, 1990.

A. Barry and S. Cohen, Quality assessment of genomic DNA degradation: alternative to gel electrophoresis overcomes limitations of traditional methods, Genet. Eng. Biotechnol. News, vol.33, issue.16, 2013.

M. Sun, J. S. Lin, and A. E. Barron, Ultrafast, efficient separations of large-sized dsDNA in a blended polymer matrix by microfluidic chip electrophoresis: a design of experiments approach, Electrophoresis, vol.32, pp.3233-3240, 2011.

D. Wu, J. Qin, and B. Lin, Electrophoretic separations on microfluidic chips, J. Chromatogr. A, vol.1184, pp.542-559, 2008.

R. A. White-3rd, P. C. Blainey, H. C. Fan, and S. R. Quake, Digital PCR provides sensitive and absolute calibration for high throughput sequencing, BMC Genomics, vol.10, p.116, 2009.

Z. L. Fang and Q. Fang, Development of a low-cost microfluidic capillary-electrophoresis system coupled with flow-injection and sequential-injection sample introduction (review), Fresenius J. Anal. Chem, vol.370, pp.978-983, 2001.

, Assessment of DNA Integrity

S. A. Bustin, V. Benes, J. A. Garson, J. Hellemans, J. Huggett et al., The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments, Clin. Chem, vol.55, pp.611-622, 2009.

M. J. Brisco, S. Latham, P. A. Bartley, and A. A. Morley, Incorporation of measurement of DNA integrity into qPCR assays, Biotechniques, vol.49, pp.893-897, 2010.

E. H. Van-beers, S. A. Joosse, M. J. Ligtenberg, R. Fles, F. B. Hogervorst et al., A multiplex PCR predictor for aCGH success of FFPE samples, Br. J. Cancer, vol.94, pp.333-337, 2006.

F. Wang, L. Wang, C. Briggs, E. Sicinska, S. M. Gaston et al., DNA degradation test predicts success in whole-genome amplification from diverse clinical samples, J. Mol. Diagn, vol.9, pp.441-451, 2007.

J. A. Walker, G. E. Kilroy, J. Xing, J. Shewale, S. K. Sinha et al., Human DNA quantitation using Alu element-based polymerase chain reaction, Anal. Biochem, vol.315, pp.122-128, 2003.

K. L. Swango, M. D. Timken, M. D. Chong, and M. R. Buoncristiani, A quantitative PCR assay for the assessment of DNA degradation in forensic samples, Forensic Sci. Int, vol.158, pp.14-26, 2006.

A. Siwoski, A. Ishkanian, C. Garnis, L. Zhang, M. Rosin et al., An efficient method for the assessment of DNA quality of archival microdissected specimens, Mod. Pathol, vol.15, pp.889-892, 2002.

S. Sah, L. Chen, J. Houghton, J. Kemppainen, A. C. Marko et al., Functional DNA quantification guides accurate next-generation sequencing mutation detection in formalin-fixed, paraffin-embedded tumor biopsies, Genome Med, vol.5, p.77, 2013.

A. Didelot, D. Le-corre, A. Luscan, A. Cazes, K. Pallier et al., Competitive allele specific TaqMan PCR for KRAS, BRAF and EGFR mutation detection in clinical formalin fixed paraffin embedded samples, Exp. Mol. Pathol, vol.92, pp.275-280, 2012.

C. Schander, H. M. Kenneth, and D. , Org. Divers. Evol, vol.3, pp.195-205, 2003.

M. Srinivasan, D. Sedmak, and S. Jewell, Effect of fixatives and tissue processing on the content and integrity of nucleic acids, Am. J. Pathol, vol.161, pp.1961-1971, 2002.

F. Salvianti, P. Pinzani, P. Verderio, C. M. Ciniselli, D. Massi et al., Multiparametric analysis of cell-free DNA in melanoma patients, PLoS One, vol.7, issue.11, p.49843, 2012.

P. Pinzani, F. Salvianti, S. Zaccara, D. Massi, V. Giorgi et al., Circulating cell-free DNA in plasma of melanoma patients: qualitative and quantitative considerations, Clin. Chim. Acta, vol.412, pp.2141-2145, 2011.

N. Umetani, A. E. Giuliano, S. H. Hiramatsu, F. Amersi, T. Nakagawa et al., Prediction of breast tumor progression by integrity of free circulating DNA in serum, J. Clin. Oncol, vol.24, pp.4270-4276, 2006.

P. Tangkijvanich, N. Hourpai, P. Rattanatanyong, N. Wisedopas, V. Mahachai et al., Serum LINE-1 hypomethylation as a potential prognostic marker for hepatocellular carcinoma, Clin. Chim. Acta, vol.379, pp.127-133, 2007.

N. Umetani, J. Kim, S. Hiramatsu, H. A. Reber, O. J. Hines et al., Increased integrity of free circulating DNA in sera of patients with colorectal or periampullary cancer: direct quantitative PCR for ALU repeats, Clin. Chem, vol.52, pp.1062-1069, 2006.

E. Sunami, A. T. Vu, S. L. Nguyen, A. E. Giuliano, and D. S. Hoon, Quantification of LINE1 in circulating DNA as a molecular biomarker of breast cancer, Ann. N. Y. Acad. Sci, vol.1137, pp.171-174, 2008.

M. A. Batzer and P. L. Deininger, Alu repeats and human genomic diversity, Nat. Rev. Genet, vol.3, pp.370-379, 2002.

E. Zonta,

J. Hasler, T. Samuelsson, and K. Strub, Useful 'junk': alu RNAs in the human transcriptome, Cell. Mol. Life Sci, vol.64, pp.1793-1800, 2007.

B. Bodega and V. Orlando, Repetitive elements dynamics in cell identity programming, maintenance and disease, Curr. Opin. Cell Biol, vol.31, pp.67-73, 2014.

E. A. Bennett, H. Keller, R. E. Mills, S. Schmidt, J. V. Moran et al., Active Alu retrotransposons in the human genome, Genome Res, vol.18, pp.1875-1883, 2008.

E. M. Wolff, H. M. Byun, H. F. Han, S. Sharma, P. W. Nichols et al., Hypomethylation of a LINE-1 promoter activates an alternate transcript of the MET oncogene in bladders with cancer, PLoS Genet, vol.6, issue.4, p.1000917, 2010.

P. Laurent-puig, D. Pekin, C. Normand, S. K. Kotsopoulos, P. Nizard et al., Clinical relevance of KRAS-mutated sub-clones detected with picodroplet digital PCR in advanced colorectal cancer treated with anti-EGFR therapy, Clin. Cancer Res, vol.21, issue.5, pp.1087-1097, 2015.

J. Lehner, O. J. Stotzer, D. M. Fersching, D. Nagel, and S. Holdenrieder, Plasma DNA integrity indicates response to neoadjuvant chemotherapy in patients with locally confined breast cancer, Int. J. Clin. Pharmacol. Ther, vol.51, pp.59-62, 2013.

T. B. Hao, W. Shi, X. J. Shen, J. Qi, X. H. Wu et al., Circulating cell-free DNA in serum as a biomarker for diagnosis and prognostic prediction of colorectal cancer, Br. J. Cancer, vol.111, pp.1482-1489, 2014.

R. Mead, M. Duku, P. Bhandari, and I. A. Cree, Circulating tumour markers can define patients with normal colons, benign polyps, and cancers, Br. J. Cancer, vol.105, pp.239-245, 2011.

F. Mouliere, B. Robert, E. Peyrotte, M. Rio, M. Ychou et al., High fragmentation characterizes tumour-derived circulating DNA, PLoS One, vol.6, issue.9, p.23418, 2011.

F. Mouliere, S. E. Messaoudi, D. Pang, A. Dritschilo, and A. R. Thierry, Multi-marker analysis of circulating cell-free DNA toward personalized medicine for colorectal cancer, Mol. Oncol, vol.8, pp.927-941, 2014.
URL : https://hal.archives-ouvertes.fr/inserm-01076572

J. Lehner, O. J. Stotzer, D. Fersching, D. Nagel, and S. Holdenrieder, Circulating plasma DNA and DNA integrity in breast cancer patients undergoing neoadjuvant chemotherapy, Clin. Chim. Acta, vol.425, pp.206-211, 2013.

D. Madhavan, M. Wallwiener, K. Bents, M. Zucknick, J. Nees et al., Plasma DNA integrity as a biomarker for primary and metastatic breast cancer and potential marker for early diagnosis, Breast Cancer Res. Treat, vol.146, pp.163-174, 2014.

U. Deligezer, Y. Eralp, E. Z. Akisik, E. E. Akisik, P. Saip et al., Effect of adjuvant chemotherapy on integrity of free serum DNA in patients with breast cancer, Ann. N. Y. Acad. Sci, vol.1137, pp.175-179, 2008.

U. Deligezer, Y. Eralp, E. Ebru, Z. Elif, P. Saip et al., Size distribution of circulating cell-free DNA in sera of breast cancer patients in the course of adjuvant chemotherapy, Clin. Chem. Lab. Med, vol.46, issue.3, pp.311-317, 2008.

O. St?-otzer, J. Lehner, D. Fersching-gierlich, D. Nagel, and S. Holdenrieder, Diagnostic relevance of plasma DNA and DNA integrity for breast cancer, Tumour Biol, vol.35, pp.1183-1191, 2014.

B. Schmidt, S. Weickmann, C. Witt, and M. Fleischhacker, Integrity of cell-free plasma DNA in patients with lung cancer and nonmalignant lung disease, Ann. N. Y. Acad. Sci, vol.1137, pp.207-213, 2008.

K. B. Sriram, V. Relan, B. E. Clarke, E. E. Duhig, M. N. Windsor et al., Pleural fluid cell-free DNA integrity index to identify cytologically negative malignant pleural effusions including mesotheliomas, BMC Cancer, vol.12, pp.428-439, 2012.

J. Ellinger, P. J. Bastian, K. I. Haan, L. C. Heukamp, R. Buettner et al., Noncancerous PTGS2 DNA fragments of apoptotic origin in sera of prostate cancer 239

, Assessment of DNA Integrity patients qualify as diagnostic and prognostic indicators, Int. J. Cancer, vol.122, pp.138-143, 2008.

R. Hanley, K. M. Rieger-christ, D. Canes, N. R. Emara, A. P. Shuber et al., DNA integrity assay: a plasma-based screening tool for the detection of prostate cancer, Clin. Cancer Res, vol.12, pp.4569-4574, 2006.

J. Ellinger, V. Wittkamp, P. Albers, F. G. Perabo, S. C. Mueller et al., Cell-free circulating DNA: diagnostic value in patients with testicular germ cell cancer, J. Urol, vol.181, pp.363-371, 2009.

J. Ellinger, P. Albers, S. C. M?-uller, A. Von-ruecker, and P. J. Bastian, Circulating mitochondrial DNA in the serum of patients with testicular germ cell cancer as a novel noninvasive diagnostic biomarker, BJU Int, vol.104, pp.48-52, 2009.

J. Ellinger, D. C. M?-uller, S. C. M?-uller, S. Hauser, L. C. Heukamp et al., Circulating mitochondrial DNA in serum: a universal diagnostic biomarker for patients with urological malignancies, Urol. Oncol, vol.30, pp.509-515, 2012.

W. W. Jiang, M. Zahurak, D. Goldenberg, Y. Milman, H. L. Park et al., Increased plasma DNA integrity index in head and neck cancer patients, Int. J. Cancer, vol.119, pp.2673-2676, 2006.

S. Holdenrieder, A. Burges, O. Reich, F. W. Spelsberg, and P. Stieber, DNA integrity in plasma and serum of patients with malignant and benign diseases, Ann. N. Y. Acad. Sci, vol.1137, pp.162-170, 2008.

F. Gang, L. Guorong, Z. An, G. Anne, G. Christian et al., Prediction of clear cell renal cell carcinoma by integrity of cell-free DNA in serum, Urology, vol.75, pp.262-265, 2010.

Y. J. Gao, Y. J. He, Z. L. Yang, H. Y. Shao, Y. Zuo et al., Increased integrity of circulating cell-free DNA in plasma of patients with acute leukemia, Clin. Chem. Lab. Med, vol.48, pp.1651-1656, 2010.

W. Shi, C. Lv, J. Qi, W. Zhao, X. Wu et al., Prognostic value of free DNA quantification in serum and cerebrospinal fluid in glioma patients, J. Mol. Neurosci, vol.46, pp.470-475, 2012.

P. J. Sykes, S. H. Neoh, M. J. Brisco, E. Hughes, J. Condon et al., Quantitation of targets for PCR by use of limiting dilution, Biotechniques, vol.13, pp.444-449, 1992.

B. Vogelstein and K. W. Kinzler, Digital PCR, Proc. Natl. Acad. Sci. U. S. A, vol.96, pp.9236-9241, 1999.

V. Taly, D. Pekin, A. E. Abed, and P. Laurent-puig, Detecting biomarkers with microdroplet technology, Trends Mol. Med, vol.18, pp.405-416, 2012.
URL : https://hal.archives-ouvertes.fr/inserm-02299585

V. Taly, D. Pekin, L. Benhaim, S. K. Kotsopoulos, D. Le-corre et al., Multiplex picodroplet digital PCR to detect KRAS mutations in circulating DNA from the plasma of colorectal cancer patients, Clin. Chem, vol.59, issue.12, pp.1722-1731, 2013.
URL : https://hal.archives-ouvertes.fr/inserm-02299581

D. Dressman, H. Yan, G. Traverso, K. W. Kinzler, and B. Vogelstein, Transforming single DNA molecules into fluorescent magnetic particles for detection and enumeration of genetic variations, Proc. Natl. Acad. Sci. U. S. A, vol.100, pp.8817-8822, 2003.

M. Nakano, J. Komatsu, S. Matsuura, K. Takashima, S. Katsura et al., Single-molecule PCR using water-in-oil emulsion, J. Biotechnol, vol.102, pp.117-124, 2003.

A. B. Theberge, F. Courtois, Y. Schaerli, M. Fischlechner, C. Abell et al., Microdroplets in microfluidics: an evolving platform for discoveries in chemistry and biology, Angew. Chem. Int. Ed. Engl, vol.49, pp.5846-5868, 2010.

D. Pekin, Y. Skhiri, J. C. Baret, D. Le-corre, L. Mazutis et al., Quantitative and sensitive detection of rare mutations using droplet-based microfluidics, Lab Chip, vol.11, issue.13, pp.2156-2166, 2011.
URL : https://hal.archives-ouvertes.fr/hal-02148770

B. J. Hindson, K. D. Ness, D. A. Masquelier, P. Belgrader, N. J. Heredia et al., High-throughput droplet digital PCR system for absolute quantitation of DNA copy number, Anal. Chem, vol.83, pp.8604-8610, 2011.

E. Zonta,

A. C. Hatch, J. S. Fisher, A. R. Tovar, A. T. Hsieh, R. Lin et al., 1-Million droplet array with wide-field fluorescence imaging for digital PCR, Lab Chip, vol.11, pp.3838-3845, 2011.

Q. Zhong, S. Bhattacharya, S. Kotsopoulos, J. Olson, V. Taly et al., Multiplex digital PCR: breaking the one target per color barrier of quantitative PCR, Lab Chip, vol.11, pp.2167-2174, 2011.
URL : https://hal.archives-ouvertes.fr/inserm-02299588

R. H. Sedlak, J. Kuypers, and K. R. Jerome, A multiplexed droplet digital PCR assay performs better than qPCR on inhibition prone samples, Diagn. Microbiol. Infect. Dis, vol.80, issue.4, pp.285-286, 2014.

N. B. Tsui, P. Jiang, K. C. Chow, X. Su, T. Y. Leung et al., High resolution size analysis of fetal DNA in the urine of pregnant women by paired-end massively parallel sequencing, PLoS One, vol.7, p.48319, 2012.

H. C. Fan, Y. J. Blumenfeld, U. Chitkara, L. Hudgins, and S. R. Quake, Analysis of the size distributions of fetal and maternal cell-free DNA by paired-end sequencing, Clin. Chem, vol.56, pp.1279-1286, 2010.

P. Jiang, C. W. Chan, K. C. Chan, S. H. Cheng, J. Wong et al., Lengthening and shortening of plasma DNA in hepatocellular carcinoma patients, Proc. Natl. Acad. Sci. U. S. A, vol.112, issue.11, pp.1317-1325, 2015.

H. C. Fan, Y. J. Blumenfeld, U. Chitkara, L. Hudgins, and S. R. Quake, Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood, Proc. Natl. Acad. Sci. U. S. A, vol.105, pp.16266-16271, 2008.

K. J. Liu, M. V. Brock, I. Shih, and T. Wang, Decoding circulating nucleic acids in human serum using microfluidic single molecule spectroscopy, J. Am. Chem. Soc, vol.132, pp.5793-5798, 2010.

K. J. Liu and T. Wang, Cylindrical illumination confocal spectroscopy: rectifying the limitations of confocal single molecule spectroscopy through one-dimensional beam shaping, Biophys. J, vol.95, pp.2964-2975, 2008.

F. Blum, Der formaldehyde als hartungsmittel, Z. Wiss. Mikr, vol.10, pp.314-315, 1893.

S. Michalik, Overcoming poor quality DNA, Drug Discov. Devel, vol.11, pp.24-30, 2008.

F. Lewis, N. J. Maughan, V. Smith, K. Hillan, and P. Quirke, Unlocking the archivegene expression in paraffin-embedded tissue, J. Pathol, vol.195, pp.66-71, 2001.

S. E. Yost, E. N. Smith, R. B. Schwab, L. Bao, H. Jung et al., Identification of high-confidence somatic mutations in whole genome sequence of formalin-fixed breast cancer specimens, Nucleic Acids Res, vol.40, issue.14, p.107, 2012.

L. F. Wessels, T. Van-welsem, A. A. Hart, L. J. Van't-veer, M. J. Reinders et al., Molecular classification of breast carcinomas by comparative genomic hybridization: a specific somatic genetic profile for BRCA1 tumors, Cancer Res, vol.62, pp.7110-7117, 2002.

E. H. Van-beers, T. Van-welsem, L. F. Wessels, Y. Li, R. A. Oldenburg et al., Comparative genomic hybridization profiles in human BRCA1 and BRCA2 breast tumors highlight differential sets of genomic aberrations, Cancer Res, vol.65, pp.822-827, 2005.

L. A. Cannon-albright, K. G. Cooper, A. Georgelas, and P. S. Bernard, High quality and quantity genome-wide germline genotypes from FFPE normal tissue, BMC Res. Notes, vol.4, p.159, 2011.

M. Gerlinger, A. J. Rowan, S. Horswell, J. Larkin, D. Endesfelder et al., Intratumor heterogeneity and branched evolution revealed by multiregion sequencing, N. Engl. J. Med, vol.366, pp.883-892, 2012.

S. E. Messaoudi, F. Rolet, F. Mouliere, and A. R. Thierry, Circulating cell free DNA: preanalytical considerations, Clin. Chim. Acta, vol.424, pp.222-230, 2013.

S. E. Polo, Reshaping chromatin after DNA Damage: the choreography of histone proteins, J. Mol. Biol, vol.427, issue.3, pp.626-636, 2015.

A. N. Butt and R. Swaminathan, Overview of circulating nucleic acids in plasma/serum, Ann. N. Y. Acad. Sci, vol.1137, pp.236-242, 2008.

P. Mandel and P. Metais, Les acides nucleiques du plasma sanguin chez lhomme, C. R. Seances Soc. Biol. Fil, vol.142, pp.241-243, 1948.

P. Pinzani, F. Salvianti, C. Orlando, and M. Pazzagli, Circulating cell-free DNA in cancer, Methods Mol. Biol, vol.1160, pp.133-145, 2014.

W. W. Jiang, B. Masayesva, M. Zahurak, A. L. Carvalho, E. Rosenbaum et al., Increased mitochondrial DNA content in saliva associated with head and neck cancer, Clin. Cancer Res, vol.11, pp.2486-2491, 2005.

S. Jahr, H. Hentze, S. Englisch, D. Hardt, F. O. Fackelmayer et al., DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells, Cancer Res, vol.61, pp.1659-1665, 2001.

F. Diehl, M. Li, D. Dressman, Y. He, D. Shen et al., Detection and quantification of mutations in the plasma of patients with colorectal tumors, Proc. Natl. Acad. Sci. U. S. A, vol.102, pp.16368-16373, 2005.

B. Ralla, C. Stephan, S. Meller, D. Dietrich, G. Kristiansen et al., Nucleic acidbased biomarkers in body fluids of patients with urologic malignancies, Crit. Rev. Clin. Lab. Sci, vol.51, pp.200-231, 2014.

F. Diehl, K. Schmidt, K. H. Durkee, K. J. Moore, S. N. Goodman et al., Analysis of mutations in DNA isolated from plasma and stool of colorectal cancer patients, Gastroenterology, vol.135, pp.489-498, 2008.

G. De-maio, C. Rengucci, W. Zoli, and D. Calistri, Circulating and stool nucleic acid analysis for colorectal cancer diagnosis, World J. Gastroenterol, vol.20, pp.957-967, 2014.

C. Rengucci, G. D. Maio, M. Menghi, E. Scarpi, S. Guglielmo et al., Improved stool DNA integrity method for early colorectal cancer diagnosis, Cancer Epidemiol. Biomarkers Prev, vol.23, pp.2553-2560, 2014.

J. Beck, H. B. Urnovitz, J. Riggert, M. Clerici, and E. Schutz, Profile of the circulating DNA in apparently healthy individuals, Clin. Chem, vol.55, pp.730-738, 2009.

E. M. Tan, P. H. Schur, R. I. Carr, and H. G. Kunkel, Deoxybonucleic acid (DNA) and antibodies to DNA in the serum of patients with systemic lupus erythematosus, J. Clin. Invest, vol.45, pp.1732-1740, 1966.

W. Ayala, L. V. Moore, and E. L. Hess, The purple color reaction given by diphenylamine reagent I with normal and rheumatic fever sera 1, J. Clin. Invest, vol.30, pp.781-785, 1951.

S. A. Leon, G. E. Ehrlich, B. Shapiro, and V. A. Labbate, Free DNA in the serum of rheumatoid arthritis patients, J. Rheumatol, vol.4, pp.139-143, 1977.

S. A. Leon, B. Shapiro, D. M. Sklaroff, and M. J. Yaros, Free DNA in the serum of cancer patients and the effect of therapy, Cancer Res, vol.37, pp.646-650, 1977.

E. Bartoloni, V. Ludovini, A. Alunno, L. Pistola, O. Bistoni et al., Increased levels of circulating DNA in patients with systemic autoimmune diseases: a possible marker of disease activity in Sjogren's syndrome, Lupus, vol.20, pp.928-935, 2011.

J. Jylhava, T. Lehtimaki, A. Jula, L. Moilanen, Y. A. Kesaniemi et al., Circulating cell-free DNA is associated with cardiometabolic risk factors: the Health, Atherosclerosis, vol.233, pp.268-271, 2000.

S. Coimbra, C. Catarino, E. Costa, H. Oliveira, A. Figueiredo et al., Circulating cell-free DNA levels in Portuguese patients with psoriasis vulgaris according to severity and therapy, Br. J. Dermatol, vol.170, pp.939-942, 2014.

J. Atamaniuk, C. Vidotto, H. Tschan, N. Bachl, K. M. Stuhlmeier et al., Increased concentrations of cell-free plasma DNA after exhaustive exercise, Clin. Chem, vol.50, pp.1668-1670, 2004.

E. Zonta,

D. J. Dwivedi, L. J. Toltl, L. L. Swystun, J. Pogue, K. L. Liaw et al., Prognostic utility and characterization of cell-free DNA in patients with severe sepsis, Crit. Care, vol.16, issue.4, p.151, 2012.

Y. M. Lo, T. H. Rainer, L. Y. Chan, N. M. Hjelm, and R. A. Cocks, Plasma DNA as a prognostic marker in trauma patients, Clin. Chem, vol.46, pp.319-323, 2000.

N. Y. Lam, T. H. Rainer, R. W. Chiu, G. M. Joynt, and Y. M. Lo, Plasma mitochondrial DNA concentrations after trauma, Clin. Chem, vol.50, pp.213-216, 2004.

Y. Shoham, Y. Krieger, Z. H. Perry, G. Shaked, A. Bogdanov-berezovsky et al., Admission cell free DNA as a prognostic factor in burns: quantification by use of a direct rapid fluorometric technique, BioMed Res. Int, issue.306580, p.5, 2014.

A. Shimony, D. Zahger, H. Gilutz, H. Goldstein, G. Orlov et al., Cell free DNA detected by a novel method in acute ST-elevation myocardial infarction patients, Acute Card. Care, vol.12, pp.109-111, 2010.

K. B. Sriram, V. Relan, B. E. Clarke, E. E. Duhig, I. A. Yang et al., Diagnostic molecular biomarkers for malignant pleural effusions, Future Oncol, vol.7, pp.737-752, 2011.

G. Perkins, T. A. Yap, L. Pope, A. M. Cassidy, J. P. Dukes et al., Multi-purpose utility of circulating plasma DNA testing in patients with advanced cancers, PLoS One, vol.7, issue.11, p.47020, 2012.

C. C. Lee, L. A. Fecher, G. L. Gallia, P. Gibbs, D. Le et al., Detection of circulating tumor DNA in early-and late-stage human malignancies, Sci. Transl. Med, vol.6, issue.224, pp.224-248, 2014.

L. A. Diaz and A. Bardelli, Liquid biopsies: genotyping circulating tumor DNA, J. Clin. Oncol, vol.32, pp.579-586, 2014.

A. M. Gown, Current issues in ER and HER2 testing by IHC in breast cancer, Mod. Pathol, vol.21, pp.8-15, 2008.

F. Lumachi, S. M. Basso, M. Bonamini, B. Marzano, E. Milan et al., Relationship between preoperative serum markers CA 15-3 and CEA and relapse of the disease in elderly (>65 years) women with breast cancer, Anticancer Res, vol.30, pp.2331-2334, 2010.

H. B. Carter, P. C. Albertsen, M. J. Barry, R. Etzioni, S. J. Freedland et al., Early detection of prostate cancer: AUA guideline, J. Urol, vol.190, pp.419-426, 2013.

S. Dawson, D. W. Tsui, M. Murtaza, H. Biggs, O. M. Rueda et al., Analysis of circulating tumor DNA to monitor metastatic breast cancer, N. Engl. J. Med, vol.368, pp.1199-1209, 2013.

N. L. Henry and D. F. Hayes, Cancer biomarkers, vol.6, pp.140-146, 2012.

G. Y. Locker, S. Hamilton, J. Harris, J. M. Jessup, N. Kemeny et al., ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer, J. Clin. Oncol, vol.24, pp.5313-5327, 2006.

A. Heidenreich, P. Abrahamsson, W. Artibani, J. Catto, F. Montorsi et al., Early detection of prostate cancer: European Association of Urology recommendation, Eur. Urol, vol.64, pp.347-354, 2013.

F. Diehl, K. Schmidt, M. A. Choti, K. Romans, S. Goodman et al., Circulating mutant DNA to assess tumor dynamics, Nat. Med, vol.14, pp.985-990, 2008.

M. Fleischhacker and B. Schmidt, Circulating nucleic acids (CNAs) and cancer-a survey, Biochim. Biophys. Acta, vol.1775, pp.181-232, 2007.

B. Shapiro, M. Chakrabarty, E. M. Cohn, and S. A. Leon, Determination of circulating DNA levels in patients with benign or malignant gastrointestinal disease, Cancer, vol.51, pp.2116-2120, 1983.

, Assessment of DNA Integrity

E. Flamini, L. Mercatali, O. Nanni, D. Calistri, R. Nunziatini et al., Free DNA and carcinoembryonic antigen serum levels: an important combination for diagnosis of colorectal cancer, Clin. Cancer Res, vol.12, pp.6985-6988, 2006.

M. Frattini, G. Gallino, S. Signoroni, D. Balestra, L. Lusa et al., Quantitative and qualitative characterization of plasma DNA identifies primary and recurrent colorectal cancer, Cancer Lett, vol.263, pp.170-181, 2008.

T. Lecomte, N. Ceze, E. Dorval, and P. Laurent-puig, Circulating free tumor DNA and colorectal cancer, Gastroenterol. Clin. Biol, vol.34, pp.662-681, 2010.
URL : https://hal.archives-ouvertes.fr/hal-00618040

E. Heitzer, P. Ulz, and J. B. Geigl, Circulating tumor DNA as a liquid biopsy for cancer, Clin. Chem, vol.61, pp.112-123, 2015.

M. Van-der, P. J. Vaart, and . Pretorius, Is the role of circulating DNA as a biomarker of cancer being prematurely overrated?, Clin. Biochem, vol.43, pp.26-36, 2010.

A. S. Devonshire, A. S. Whale, A. Gutteridge, G. Jones, S. Cowen et al., Towards standardisation of cell-free DNA measurement in plasma: controls for extraction efficiency, fragment size bias and quantification, Anal. Bioanal. Chem, vol.406, pp.6499-6512, 2014.

N. A. Biochemistry,

T. Lecomte, A. Berger, F. Zinzindohoue, S. Micard, B. Landi et al., Detection of free-circulating tumor-associated DNA in plasma of colorectal cancer patients and its association with prognosis, Int. J. Cancer, vol.100, pp.542-548, 2002.

G. D. Sorenson, D. M. Pribish, F. H. Valone, V. A. Memoli, D. J. Bzik et al., Soluble normal and mutated DNA sequences from single-copy genes in human blood, Cancer Epidemiol. Biomarkers Prev, vol.3, pp.67-71, 1994.

G. D. Sorenson, Detection of mutated KRAS2 sequences as tumor markers in plasma/serum of patients with gastrointestinal cancer, Clin. Cancer Res, vol.6, pp.2129-2137, 2000.

H. E. Mulcahy, J. Lyautey, C. Lederrey, X. Chen, P. Anker et al., A prospective study of K-ras mutations in the plasma of pancreatic cancer patients, Clin. Cancer Res, vol.4, pp.271-275, 1998.

K. Jung, M. Fleischhacker, and A. Rabien, Cell-free DNA in the blood as a solid tumor biomarker-a critical appraisal of the literature, Clin. Chim. Acta, vol.411, pp.1611-1624, 2010.

Y. I. Elshimali, H. Khaddour, M. Sarkissyan, Y. Wu, and J. V. Vadgama, The clinical utilization of circulating cell free DNA (CCFDNA) in blood of cancer patients, Int. J. Mol. Sci, vol.14, pp.18925-18958, 2013.

J. Wagner, Free DNA-new potential analyte in clinical laboratory diagnostics?, Biochem. Med. (Zagreb), pp.24-38, 2012.

J. Yu, G. Gu, and S. Ju, Recent advances in clinical applications of circulating cell-free DNA integrity, Lab. Med, vol.45, pp.6-11, 2014.

A. Sita-lumsden, C. E. Fletcher, D. A. Dart, G. N. Brooke, J. Waxman et al., Circulating nucleic acids as biomarkers of prostate cancer, Biomark. Med, vol.7, pp.867-877, 2013.

S. H. Lim, T. M. Becker, W. Chua, N. J. Caixeiro, W. L. Ng et al., Circulating tumour cells and circulating free nucleic acid as prognostic and predictive biomarkers in colorectal cancer, Cancer Lett, vol.346, pp.24-33, 2014.

D. M. Marzese, H. Hirose, and D. S. Hoon, Diagnostic and prognostic value of circulating tumor-related DNA in cancer patients, Expert Rev. Mol. Diagn, vol.13, pp.827-844, 2013.

E. Crowley, F. D. Nicolantonio, F. Loupakis, and A. Bardelli, Liquid biopsy: monitoring cancer-genetics in the blood, Nat. Rev. Clin. Oncol, vol.10, pp.472-484, 2013.

H. Wiksell, K. U. Schassburger, M. Janicijevic, K. Leifland, L. Lofgren et al., Prevention of tumour cell dissemination in diagnostic needle procedures, Br. J. Cancer, vol.103, issue.11, pp.1706-1709, 2010.

C. F. Loughran and C. R. Keeling, Seeding of tumour cells following breast biopsy: a literature review, Br. J. Radiol, vol.84, pp.869-874, 2011.

P. L. Bedard, A. R. Hansen, M. J. Ratain, and L. L. Siu, Tumour heterogeneity in the clinic, Nature, vol.501, pp.355-364, 2013.

A. Esposito, A. Bardelli, C. Criscitiello, N. Colombo, L. Gelao et al., Monitoring tumor-derived cell-free DNA in patients with solid tumors: clinical perspectives and research opportunities, Cancer Treat. Rev, vol.40, pp.648-655, 2014.

L. A. Diaz and A. Bardelli, Liquid biopsies: genotyping circulating tumor DNA, J. Clin. Oncol, vol.32, pp.579-586, 2014.

S. Misale, R. Yaeger, S. Hobor, E. Scala, M. Janakiraman et al., Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer, Nature, vol.486, pp.532-536, 2012.

M. Li, W. D. Chen, N. Papadopoulos, S. N. Goodman, N. C. Bjerregaard et al., Sensitive digital quantification of DNA methylation in clinical samples, Nat. Biotechnol, vol.27, pp.858-863, 2009.

A. L. Richardson and J. D. Iglehart, BEAMing up personalized medicine: mutation detection in blood, Clin. Cancer Res, vol.18, pp.3209-3211, 2012.

V. Vescovo, M. Grasso, M. Barbareschi, and M. Denti, MicroRNAs as lung cancer biomarkers, World J. Clin. Oncol, vol.5, pp.604-620, 2014.

E. Yong, Cancer biomarkers: written in blood, Nature, vol.511, p.524, 2014.

M. Van-der, P. J. Vaart, and . Pretorius, Circulating DNA. Its origin and fluctuation, Ann. N. Y. Acad. Sci, vol.1137, pp.18-26, 2008.
URL : https://hal.archives-ouvertes.fr/hal-01836273

M. Stroun, J. Lyautey, C. Lederrey, A. Olson-sand, and P. Anker, About the possible origin and mechanism of circulating DNA apoptosis and active DNA release, Clin. Chim. Acta, vol.313, pp.139-142, 2001.

Y. M. Lo, J. Zhang, T. N. Leung, T. K. Lau, A. M. Chang et al., Rapid clearance of fetal DNA from maternal plasma, Am. J. Hum. Genet, vol.64, pp.218-224, 1999.

S. C. Yu, S. W. Lee, P. Jiang, T. Y. Leung, K. C. Chan et al., Highresolution profiling of fetal DNA clearance from maternal plasma by massively parallel sequencing, Clin. Chem, vol.59, pp.1228-1237, 2013.

L. Galluzzi, O. Kepp, S. Krautwald, G. Kroemer, and A. Linkermann, Molecular mechanisms of regulated necrosis, Semin. Cell Dev. Biol, vol.35, pp.24-32, 2014.

G. W. Dorn-2nd, Molecular mechanisms that differentiate apoptosis from programmed necrosis, Toxicol. Pathol, vol.41, pp.227-234, 2013.

G. Wickman, L. Julian, and M. F. Olson, How apoptotic cells aid in the removal of their own cold dead bodies, Cell Death Differ, vol.19, pp.735-742, 2012.

M. Van-der, P. J. Vaart, and . Pretorius, The origin of circulating free DNA, Clin. Chem, vol.53, p.2215, 2007.

H. Schwarzenbach, D. S. Hoon, and K. Pantel, Cell-free nucleic acids as biomarkers in cancer patients, Nat. Rev. Cancer, vol.11, pp.426-437, 2011.

F. Mouliere and A. R. Thierry, The importance of examining the proportion of circulating DNA originating from tumor, microenvironment and normal cells in colorectal cancer patients, Expert Opin. Biol. Ther, vol.12, pp.209-215, 2012.

D. C. Garcia-olmo, J. Samos, M. G. Picazo, A. I. Asensio, I. Toboso et al., Release of cell-free DNA into the bloodstream leads to high levels of nontumor plasma DNA during tumor progression in rats, Cancer Lett, vol.272, pp.133-140, 2008.

A. R. Thierry, F. Mouliere, C. Gongora, J. Ollier, B. Robert et al., Origin and quantification of circulating DNA in mice with human colorectal cancer xenografts, Nucleic Acids Res, vol.38, pp.6159-6175, 2010.

A. M. Newman, S. V. Bratman, J. To, J. F. Wynne, N. C. Eclov et al., An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage, Nat. Med, vol.20, pp.548-554, 2014.

, Assessment of DNA Integrity

J. M. Silva, J. Silva, A. Sanchez, J. M. Garcia, G. Dominguez et al., Tumor DNA in plasma at diagnosis of breast cancer patients is a valuable predictor of disease-free survival, Clin. Cancer Res, vol.8, pp.3761-3766, 2002.

C. Alix-panabieres, H. Schwarzenbach, and K. Pantel, Circulating tumor cells and circulating tumor DNA, Annu. Rev. Med, vol.63, pp.199-215, 2012.
URL : https://hal.archives-ouvertes.fr/hal-01872958

K. Koyanagi, T. Mori, S. J. O'day, S. R. Martinez, H. J. Wang et al., Association of circulating tumor cells with serum tumor-related methylated DNA in peripheral blood of melanoma patients, Cancer Res, vol.66, pp.6111-6117, 2006.

D. S. Hoon, M. Spugnardi, C. Kuo, S. K. Huang, D. L. Morton et al., Profiling epigenetic inactivation of tumor suppressor genes in tumors and plasma from cutaneous melanoma patients, Oncogene, vol.23, pp.4014-4022, 2004.

O. Surova and B. Zhivotovsky, Various modes of cell death induced by DNA damage, Oncogene, vol.32, pp.3789-3797, 2013.

D. Hanahan and R. A. Weinberg, Hallmarks of cancer: the next generation, Cell, vol.144, pp.646-674, 2011.

H. Schwarzenbach, J. Stoehlmacher, K. Pantel, and E. Goekkurt, Detection and monitoring of cell-free DNA in blood of patients with colorectal cancer, Ann. N. Y. Acad. Sci, vol.1137, pp.190-196, 2008.

K. C. Chan, S. F. Leung, S. W. Yeung, A. T. Chan, and Y. M. Lo, Persistent aberrations in circulating DNA integrity after radiotherapy are associated with poor prognosis in nasopharyngeal carcinoma patients, Clin. Cancer Res, vol.14, pp.4141-4145, 2008.

R. Salani, B. Davidson, M. Fiegl, C. Marth, E. Muller-holzner et al., Measurement of cyclin E genomic copy number and strand length in cell-free DNA distinguish malignant versus benign effusions, Clin. Cancer Res, vol.13, pp.5805-5809, 2007.

M. T. Gilbert, T. Haselkorn, M. Bunce, J. J. Sanchez, S. B. Lucas et al., The isolation of nucleic acids from fixed, paraffin-embedded tissues-which methods are useful when?, PLoS One, vol.2, issue.6, p.537, 2007.

Y. M. Lo, M. S. Tein, T. K. Lau, C. J. Haines, T. N. Leung et al., Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis, Am. J. Hum. Genet, vol.62, pp.768-775, 1998.

F. M. Lun, R. W. Chiu, K. C. Chan, T. Y. Leung, T. K. Lau et al., Microfluidics digital PCR reveals a higher than expected fraction of fetal DNA in maternal plasma, Clin. Chem, vol.54, pp.1664-1672, 2008.

H. Yu, Y. Shen, Q. Ge, Y. He, D. Qiao et al., Quantification of maternal serum cell-free fetal DNA in early-onset preeclampsia, Int. J. Mol. Sci, vol.14, pp.7571-7582, 2013.

M. Smid, S. Galbiati, A. Lojacono, L. Valsecchi, C. Platto et al., Correlation of fetal DNA levels in maternal plasma with Doppler status in pathological pregnancies, Prenat. Diagn, vol.26, pp.785-790, 2006.

K. C. Chan, J. Zhang, A. B. Hui, N. Wong, T. K. Lau et al., Size distributions of maternal and fetal DNA in maternal plasma, Clin. Chem, vol.50, pp.88-92, 2004.

R. Menkveld, Clinical significance of the low normal sperm morphology value as proposed in the fifth edition of the WHO Laboratory Manual for the Examination and Processing of Human Semen, Asian J. Androl, vol.12, pp.47-58, 2010.

M. B. Shamsi, S. N. Imam, and R. Dada, Sperm DNA integrity assays: diagnostic and prognostic challenges and implications in management of infertility, J. Assist. Reprod. Genet, vol.28, pp.1073-1085, 2011.

A. Agarwal and T. M. Said, Role of sperm chromatin abnormalities and DNA damage in male infertility, Hum. Reprod. Update, vol.9, pp.331-345, 2003.

A. Ahmadi and S. C. Ng, Fertilizing ability of DNA-damaged spermatozoa, J. Exp. Zool, vol.284, pp.696-704, 1999.

M. Bungum, Sperm DNA integrity assessment: a new tool in diagnosis and treatment of fertility, Obstet. Gynecol. Int, vol.2012, pp.1-6, 2012.